Tuesday, March 29, 2022 11:36:48 AM
Perhaps I've forgotten how to read in my years, but where on that page does it say they have started the fast track application?
It certainly says they intend to; it doesn't say the process has begun.
For ADVA, it states that upcoming milestones are:
Now tell me, how can they be in the process of filing the IND application when the IND enabling studies haven't even occured?
And the 'anti-viral program' (note, no longer "SBFM-PL4", I suspect because SBFM-PL4 has failed) is even further behind.
So, no, I'm not calling SBFM liars. But I am calling someone a liar.
It certainly says they intend to; it doesn't say the process has begun.
For ADVA, it states that upcoming milestones are:
? GMP Manufacturing (5 Kilograms)
? IND-Enabling Studies
? Filing of IND Application (“Fast-Track” anticipated)
? Phase I Clinical Trials (Pancreatic Cancer, Jewish General Hospital)
Now tell me, how can they be in the process of filing the IND application when the IND enabling studies haven't even occured?
And the 'anti-viral program' (note, no longer "SBFM-PL4", I suspect because SBFM-PL4 has failed) is even further behind.
So, no, I'm not calling SBFM liars. But I am calling someone a liar.
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
